Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

21.9K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.9K
Proteomics01:33

Proteomics

10.1K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A katE katG double-knockout E. coli strain eliminates the risk of catalase contamination in recombinant proteins.

Applied microbiology and biotechnology·2026
Same author

Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome.

Journal of medicinal chemistry·2025
Same author

Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders.

ACS medicinal chemistry letters·2025
Same author

Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors - a review of patent literature from 2019-June 2023.

Expert opinion on therapeutic patents·2024
Same author

Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors - a review of patent literature from 2019-30 June 2023.

Expert opinion on therapeutic patents·2024
Same author

A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assays.

Bioengineering & translational medicine·2023

Related Experiment Video

Updated: Mar 16, 2026

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.8K

Selectivity Determination of a Small Molecule Chemical Probe Using Protein Microarray and Affinity Capture

Erik C Hett1, Robert E Kyne2, Ariamala Gopalsamy1

  • 1Medicine Design, Pfizer , 610 Main Street, Cambridge, Massachusetts 02139, United States.

ACS Combinatorial Science
|August 6, 2016
PubMed
Summary

This study demonstrates how a tritiated probe and protein microarray effectively assess drug selectivity for the DcpS enzyme. Diaminoquinazoline inhibitors show excellent selectivity, validating these methods for drug discovery.

Keywords:
affinity enrichmentcap-binding proteinchemical probeprotein microarray

More Related Videos

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

13.4K
Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions
08:07

Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions

Published on: August 2, 2015

8.5K

Related Experiment Videos

Last Updated: Mar 16, 2026

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.8K
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

13.4K
Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions
08:07

Probing High-density Functional Protein Microarrays to Detect Protein-protein Interactions

Published on: August 2, 2015

8.5K

Area of Science:

  • Chemical biology
  • Drug discovery
  • Biochemistry

Background:

  • Small molecule selectivity is critical for drug development and target validation.
  • Understanding off-target effects requires advanced protein profiling technologies.

Purpose of the Study:

  • To evaluate the binding selectivity of a DcpS enzyme inhibitor.
  • To showcase the utility of protein microarrays and affinity enrichment in drug discovery.

Main Methods:

  • Utilized a tritiated chemical probe and a human protein microarray (9000 proteins).
  • Employed immobilized m7GTP resin for assessing selectivity against mRNA cap-associated proteins in cell extracts.

Main Results:

  • Confirmed the exquisite selectivity of diaminoquinazoline inhibitors for DcpS.
  • Demonstrated the effectiveness of protein microarrays for broad protein profiling.

Conclusions:

  • Protein microarray and affinity enrichment are valuable tools for assessing drug candidate selectivity.
  • These methods aid in understanding off-target effects and validating drug targets.